In utero trophoblast transgenesis

Active Project Grant Awarded Last action

Award ID
R21HD112763
Recipient
Awarding agency
Obligated
$776,592

Award facts

Completion date 86% complete
Originally
Place of performance
Dayton, OH 45435, USA

Award details come from USAspending.gov.

Description

Abstract
The placenta is a unique organ that develops during pregnancy and is essential for survival and growth of the developing fetus. A major obstacle in understanding the role of potential mediators of placental development has been the lack of a facile method for trophoblast gene manipulation in intact animals. Lentiviral infection of blastocysts in cell culture [EX vivo] and subsequent embryo transfer is an established technique that leads to trophoblast gene transfer. Despite its introduction several years ago, the use of this EX vivo embryo transfer approach to achieve trophoblast gene modulation has been limited. This is not likely due to a lack of need for these techniques, as IT provides a powerful tool to assess placental development and dysfunction. The reasons for its limited use are likely due to the requirement for highly specialized staff, the technically involved process, and the need to culture blastocysts in vitro to infect before embryo transfer. To overcome the limitations of EX vivo gene transfer, we have devised and propose to validate a novel in utero trophoblast transgenesis approach, in which nonsurgical lentiviral infection of blastocysts occurs in utero and provides trophoblast-specific gene expression in naturally mated pregnant females. This method will provide the ability to evaluate numerous genes in a rapid and highly efficient way to study the role of the placenta in development and disease states. This method is straightforward, specific, does not require highly specialized staff, and eliminates the use of anesthetic. In addition, the rate of pregnancy and pups/pregnancy is the same naturally mated mice. Completion of the proposed aims will provide a new and powerful way to determine the processes that regulate placentation and underlying factors involved in the development of pregnancy-associated disorders in a highly accelerated manner.

Transactions

Action Obligated Date
Amendment $0
Amendment $172,479
Amendment $172,479
Amendment $215,817
Original award $215,817

Subawards

Subrecipient Amount Awarded
Queens University At Kingston Oversee the assessment and evaluation of mouse placental histology resulting from experiments conducted at Wright State University. $48,556

Quick answers

Who received award R21HD112763?

R21HD112763 was awarded to Wright State University by National Institute of Child Health and Human Development (National Institutes of Health) on April 1, 2024.

How much is award R21HD112763 worth?

$776,592 has been obligated on R21HD112763.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award